Please login to the form below

Not currently logged in
Email:
Password:

OPKO appoints vice president of medical affairs

Dr Douglass Laidlaw brings experience from Relypsa and Sanofi

OPKO Health Dr Douglass LaidlawMiami-based OPKO Health has appointed Dr Douglass Laidlaw as vice president of medical affairs.

In his new role, Dr Laidlaw will be particularly responsible for overseeing the anticipated launch of the healthcare company's product Rayaldee.

Dr Laidlaw has over 15 years of experience in leading strategic planning, development and execution of medical education initiatives for numerous pharmaceutical companies, which include Genzyme, Keryx, Neurocine Biosciences and Serono.

He previously served as Relypsa's executive director, medical affairs and Sanofi's national director for medical science liasons, medical affairs.

Philip Frost, chairman and chief executive of OPKO, said: “Doug is a key addition to the management team in OPKO's renal division.

“A well-conceived and executed medical education strategy is critical to Rayaldee's acceptance by US healthcare professionals.”

6th June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Menopause-thumbnail.png
Breaking the silence: It’s time to talk about the menopause
Using findings from our latest opinion poll, Vicki Newlove outlines why the hidden landscape of menopause may finally be starting to change....
Committing time to making meaningful connections - top 5 tips
Read the second blog of the series looking at key barriers to effective patient engagement in pharma...
News:
Senior Analytics Specialist joins Research Partnership...